PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey


Fici F., Bakir E. A., ÖZÇELİK Ş., Makel W., Robles N. R.

PRIMARY CARE DIABETES, cilt.12, sa.6, ss.558-564, 2018 (SCI-Expanded)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.pcd.2018.08.008
  • Dergi Adı: PRIMARY CARE DIABETES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.558-564
  • Anahtar Kelimeler: Albuminuria, Diabetes, Hypertension, RAAS inhibitors, CHRONIC KIDNEY-DISEASE, GLOMERULAR-FILTRATION-RATE, CARDIOVASCULAR RISK-FACTORS, COLLABORATIVE METAANALYSIS, GLUCOSE CONTROL, BLOOD-PRESSURE, RENAL-DISEASE, MICROALBUMINURIA, POPULATION, OUTCOMES
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Background: Albuminuria is an early marker of kidney disease in patients with diabetes and/or hypertension undetected or untreated albuminuria is a leading cause of chronic kidney disease and cardiovascular events, The purpose of the present survey was to assess the prevalence of albuminuria in patients with diabetes and hypertension, treated with a combinations of renin angiotensin aldosterone system inhibitors and dihydropyridine calcium channel blockers.